• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B型血友病患者进行心脏大手术时使用重组FIX Fc融合蛋白替代治疗:一例报告

Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report.

作者信息

Bohn Jan-Paul, Fiala Anna, Bachmann Sebastian, Irsara Christian, Wolf Dominik, Feistritzer Clemens

机构信息

Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.

Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Ther Adv Hematol. 2022 Jul 26;13:20406207221104595. doi: 10.1177/20406207221104595. eCollection 2022.

DOI:10.1177/20406207221104595
PMID:35923771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9340359/
Abstract

The introduction of extended factor IX (FIX) products has significantly facilitated the treatment of hemophilia B patients. However, optimal perioperative management remains a topic of hot debate, particularly in surgeries with high bleeding risk. For the first time, we report here a patient with mild hemophilia B and degenerative aneurysms of aortic root and ascending aorta undergoing elective Bentall's operation with full cardiopulmonary bypass, who was successfully managed with eftrenonacog alfa (Alprolix), a recombinant FIX Fc fusion protein (rFIXFc). rFIXFc could safely be monitored using the Pathromtin SL aPTT-reagent. No significant bleeding was noted intraoperatively despite systemic heparinization as well as postoperatively. Higher doses of rFIXFc were inevitable to reach target FIX levels intraoperatively, whereas in the post-surgery setting stable FIX concentrations were maintained with only few rFIXFc injections facilitating fast wound healing and remobilization of the patient.

摘要

延长型凝血因子IX(FIX)产品的引入显著促进了B型血友病患者的治疗。然而,围手术期的最佳管理仍然是一个激烈争论的话题,尤其是在出血风险高的手术中。我们首次在此报告一名患有轻度B型血友病以及主动脉根部和升主动脉退行性动脉瘤的患者,该患者接受了择期Bentall手术并进行了全心肺转流,使用重组FIX Fc融合蛋白(rFIXFc)eftrenonacog alfa(Alprolix)成功进行了管理。rFIXFc可以使用Pathromtin SL aPTT试剂进行安全监测。尽管术中进行了全身肝素化以及术后,均未观察到明显出血。术中不可避免地需要更高剂量的rFIXFc才能达到目标FIX水平,而在术后仅需注射少量rFIXFc就能维持稳定的FIX浓度,这有利于患者伤口快速愈合和活动恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/855c/9340359/c1d879c3224f/10.1177_20406207221104595-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/855c/9340359/c1d879c3224f/10.1177_20406207221104595-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/855c/9340359/c1d879c3224f/10.1177_20406207221104595-fig1.jpg

相似文献

1
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report.B型血友病患者进行心脏大手术时使用重组FIX Fc融合蛋白替代治疗:一例报告
Ther Adv Hematol. 2022 Jul 26;13:20406207221104595. doi: 10.1177/20406207221104595. eCollection 2022.
2
Eftrenonacog Alfa: A Review in Haemophilia B.依非特仑那肽:用于乙型血友病的治疗。
Drugs. 2023 Jun;83(9):807-818. doi: 10.1007/s40265-023-01868-7. Epub 2023 Apr 21.
3
Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany.重组凝血因子VIII/凝血因子IX Fc在A型/ B型血友病中的真实世界应用及疗效:德国一项为期24个月的前瞻性非干预性PREVENT研究的最终数据
Res Pract Thromb Haemost. 2024 Jun 21;8(5):102482. doi: 10.1016/j.rpth.2024.102482. eCollection 2024 Jul.
4
Measurements of eftrenonacog alfa by 19 different combinations reagents/instrument: A single-centre study.用 19 种不同组合的试剂/仪器测量 eftrenonacog alfa:一项单中心研究。
Haemophilia. 2020 May;26(3):543-552. doi: 10.1111/hae.14003. Epub 2020 Apr 20.
5
Eftrenonacog Alfa: A Review in Haemophilia B.依非特仑那酚:乙型血友病的研究进展。
Drugs. 2017 Jul;77(11):1235-1246. doi: 10.1007/s40265-017-0778-1.
6
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand.在既往按需治疗的血友病患者中,使用重组因子VIII Fc或重组因子IX Fc进行预防的长期疗效。
Res Pract Thromb Haemost. 2023 Aug 9;7(6):102163. doi: 10.1016/j.rpth.2023.102163. eCollection 2023 Aug.
7
Prolonged activity of factor IX as a monomeric Fc fusion protein.IX 因子作为单体 Fc 融合蛋白的延长活性。
Blood. 2010 Mar 11;115(10):2057-64. doi: 10.1182/blood-2009-08-239665. Epub 2010 Jan 7.
8
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis.重组FIX Fc用于B型血友病的大手术:FIX血浆活性水平与有效止血
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102169. doi: 10.1016/j.rpth.2023.102169. eCollection 2023 Aug.
9
Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.重组因子IX Fc融合蛋白维持完整的促凝血特性,并在血友病B小鼠中展现出延长的疗效。
PLoS One. 2016 Feb 3;11(2):e0148255. doi: 10.1371/journal.pone.0148255. eCollection 2016.
10
Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.使用重组凝血因子VIII Fc和凝血因子IX Fc管理血友病患者的手术:3期关键研究的安全性和有效性数据。
Res Pract Thromb Haemost. 2022 Jul 26;6(5):e12760. doi: 10.1002/rth2.12760. eCollection 2022 Jul.

引用本文的文献

1
Is it safe to perform coronary artery bypass grafting surgery in patients with hemophilia? A case series of four patients.血友病患者进行冠状动脉搭桥手术是否安全?4例患者的病例系列报道
Turk Gogus Kalp Damar Cerrahisi Derg. 2025 Apr 30;33(2):251-256. doi: 10.5606/tgkdc.dergisi.2025.25800. eCollection 2025 Apr.
2
Modern Treatment of Valvulopathies in Patients with Congenital Hemophilia.先天性血友病患者瓣膜病的现代治疗
Life (Basel). 2024 Mar 7;14(3):354. doi: 10.3390/life14030354.
3
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis.

本文引用的文献

1
WFH Guidelines for the Management of Hemophilia, 3rd edition.《血友病管理的居家指南》第三版
Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3.
2
Measurements of eftrenonacog alfa by 19 different combinations reagents/instrument: A single-centre study.用 19 种不同组合的试剂/仪器测量 eftrenonacog alfa:一项单中心研究。
Haemophilia. 2020 May;26(3):543-552. doi: 10.1111/hae.14003. Epub 2020 Apr 20.
3
Off-pump technique and replacement therapy for coronary artery bypass surgery in a patient with hemophilia B.
重组FIX Fc用于B型血友病的大手术:FIX血浆活性水平与有效止血
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102169. doi: 10.1016/j.rpth.2023.102169. eCollection 2023 Aug.
B 型血友病患者行冠状动脉旁路移植术的非体外循环技术和替代治疗。
J Thromb Thrombolysis. 2019 Aug;48(2):299-302. doi: 10.1007/s11239-019-01888-9.
4
Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices.血友病 B 的围手术期管理:对证据和当前实践的批判性评估。
Haemophilia. 2017 Nov;23(6):821-831. doi: 10.1111/hae.13279. Epub 2017 Jul 27.
5
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.长效重组因子IX Fc融合蛋白(rFIXFc)用于3期B-LONG研究中B型血友病患者的围手术期管理。
Br J Haematol. 2015 Jan;168(1):124-34. doi: 10.1111/bjh.13112. Epub 2014 Sep 11.
6
Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases.罕见先天性出血性疾病中的心肌梗死及其他急性冠状动脉综合征:对所有报道病例的批判性分析
Clin Appl Thromb Hemost. 2015 May;21(4):359-64. doi: 10.1177/1076029614548056. Epub 2014 Aug 25.
7
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.血友病 B 用重组凝血因子 IX Fc 融合蛋白的 3 期研究。
N Engl J Med. 2013 Dec 12;369(24):2313-23. doi: 10.1056/NEJMoa1305074. Epub 2013 Dec 4.
8
Cardiac surgery in patients with haemophilia B: a case report and review of the literature.乙型血友病患者的心脏手术:一例病例报告及文献综述
Haemophilia. 2009 Jan;15(1):108-13. doi: 10.1111/j.1365-2516.2008.01918.x. Epub 2008 Oct 23.
9
Haemophilia B: Christmas disease.血友病B:克里斯马斯病。
Expert Opin Pharmacother. 2005 Aug;6(9):1517-24. doi: 10.1517/14656566.6.9.1517.
10
The overall effectiveness of prophylaxis in severe haemophilia.严重血友病预防治疗的总体疗效。
Haemophilia. 2003 May;9(3):272-8. doi: 10.1046/j.1365-2516.2003.00757.x.